GJ Ossenkoppele

2.9k total citations · 1 hit paper
32 papers, 2.1k citations indexed

About

GJ Ossenkoppele is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, GJ Ossenkoppele has authored 32 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 12 papers in Oncology and 10 papers in Genetics. Recurrent topics in GJ Ossenkoppele's work include Acute Myeloid Leukemia Research (6 papers), Cancer Treatment and Pharmacology (6 papers) and Acute Lymphoblastic Leukemia research (5 papers). GJ Ossenkoppele is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Cancer Treatment and Pharmacology (6 papers) and Acute Lymphoblastic Leukemia research (5 papers). GJ Ossenkoppele collaborates with scholars based in Netherlands, Italy and France. GJ Ossenkoppele's co-authors include Arjan A. van de Loosdrecht, Marjolein G. Broekhoven, R.H.J. Beelen, M. M. A. C. Langenhuijsen, J.J. Heimans, T.J. Postma, Peter C. Huijgens, Tjeerd J. Postma, GJ Schuurhuis and Jan B. Vermorken and has published in prestigious journals such as The Lancet, Blood and British Journal of Cancer.

In The Last Decade

GJ Ossenkoppele

31 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A tetrazolium-based colorimetric MTT assay to quantitate human monocyte mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemia

1994 656 citations Arjan A. van de Loosdrecht, R.H.J. Beelen et al. Journal of Immunological Methods profile →

Peers

Countries citing papers authored by GJ Ossenkoppele

Since Specialization

Citations

This map shows the geographic impact of GJ Ossenkoppele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by GJ Ossenkoppele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites GJ Ossenkoppele more than expected).

Fields of papers citing papers by GJ Ossenkoppele

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by GJ Ossenkoppele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by GJ Ossenkoppele. The network helps show where GJ Ossenkoppele may publish in the future.

Co-authorship network of co-authors of GJ Ossenkoppele

This figure shows the co-authorship network connecting the top 25 collaborators of GJ Ossenkoppele. A scholar is included among the top collaborators of GJ Ossenkoppele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with GJ Ossenkoppele. GJ Ossenkoppele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Value of infliximab (Remicade(R)) in patients with low-risk myelodysplastic syndrome: final results of a randomized phase II trial (EORTC trial 06023) of the EORTC Leukemia Group 2011 ·Haematologica ·Frédéric Baron, Stefan Suciu, Sergio Amadori, Petra Muus, H. Zwierzina, Claudio Denzlinger, Michel Delforge, A. Thyss, Dominik Selleslag, Karel Indrák, GJ Ossenkoppele, T. de Witte	21
2	Intensified chemotherapy inspired by a pediatric regimen combined with allogeneic transplantation in adult patients with acute lymphoblastic leukemia up to the age of 40 2011 ·Leukemia ·Anita W. Rijneveld, Bronno van der Holt, Simon Daenen, Bart J. Biemond, Okke de Weerdt, Petra Muus, Johan Maertens, Vera Mattijssen, H Demuynck, (unknown), P. Wijermans, S. Wittebol, (unknown), A. W. Dekker, GJ Ossenkoppele, R. Willemze, Jan J. Cornelissen, (unknown)	55
3	Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial 2010 ·Haematologica ·T. de Witte, A Hagemeijer, Stefan Suciu, Amine Belhabri, Michel Delforge, Guido Kobbe, (unknown), Harry C. Schouten, Augustin Ferrant, Harald Biersack, Sergio Amadori, Petra Muus, Joop H. Jansen, Eva Hellström‐Lindberg, Tibor Kovacsovics, P. W. Wijermans, GJ Ossenkoppele, Aloïs Gratwohl, J. P. Marie, (unknown)	52
4	Autologous stem cell transplantation in elderly patients (>=60 years) with diffuse large B-cell lymphoma: an analysis based on data in the European Blood and Marrow Transplantation registry 2008 ·Haematologica ·Esa Jantunen, (unknown), Alessandro Rambaldi, GJ Ossenkoppele, B Allione, Didier Blaise, E. Condé, Hervé Tilly, Gordon Cook, Fiona Clark, Andrea Gallamini, Alexandria Porcia Haynes, Nicolas Mounier, (unknown), Michael Pfreundschuh, (unknown), (unknown)	59
5	Mucormycosis in a patient with low risk myelodysplasia treated with anti-TNF-alpha. 2006 ·PubMed ·(unknown), Paul van der Valk, GJ Ossenkoppele, (unknown)	11
6	Expression of the polycomb-group gene BMI1 is related to an unfavourable prognosis in primary nodal DLBCL 2006 ·Journal of Clinical Pathology ·Joost C. van Galen, (unknown), Joost J. Oudejans, W Vos, (unknown), GJ Ossenkoppele, Arie P. Otte, Frank M. Raaphorst, C. J. L. M. Meijer	43
7	Identification of genes potentially involved in disease transformation of CML 2005 ·Leukemia ·J. Janssen, (unknown), Quinten Waisfisz, Gerard Pasterkamp, Dominique P.V. de Kleijn, Gerrit‐Jan Schuurhuis, GJ Ossenkoppele	27
8	Health related quality of life in patients with multiple myeloma undergoing a double transplantation 2005 ·European Journal Of Haematology ·Carin A. Uyl‐de Groot, (unknown), (unknown), GJ Ossenkoppele, H. Pieter van den Berg, Peter C. Huijgens	41
9	Extensive early apoptosis in frozen–thawed CD34-positive stem cells decreases threshold doses for haematological recovery after autologous peripheral blood progenitor cell transplantation 2002 ·Bone Marrow Transplantation ·Fransien de Boer, (unknown), (unknown), (unknown), Elsken van der Wall, (unknown), J. van der Lelie, (unknown), GJ Ossenkoppele, GJ Schuurhuis	55
10	Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study 2002 ·The Lancet ·Martin Klein, J. J. Heimans, N.K. Aaronson, (unknown), (unknown), Martin J. Muller, T.J. Postma, (unknown), (unknown), (unknown), GJ Ossenkoppele, GW van Imhoff, AW Dekker, Jelle Jolles, Ben J. Slotman, H. Struikmans, M. J. B. Taphoorn	454
11	A randomized study on the value of Fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high risk myelodysplastic syndromes and elderly AML. A report from the Dutch-Belgian hemato-oncology cooperative group (HOVON) 2001 ·Blood ·GJ Ossenkoppele, Bronno van der Holt, Pieter Sonneveld, Edo Vellenga, (unknown), Douwe H. Biesma, Petra H.M. Westveer, Georg Peters, Paul Noordhuis, Petra Muus, Wilfried J. Graveland, M Schaafsma, Dominik Selleslag, Michel Delforge, Bob Löwenberg, Gregor Verhoef	2
12	Functional characterization of minimal residual disease for P-glycoprotein and multidrug resistance protein activity in acute myeloid leukemia 2001 ·Leukemia ·(unknown), (unknown), N Feller, (unknown), Amber van Stijn, GJ Ossenkoppele, HJ Broxterman, GJ Schuurhuis	25
13	High-dose melphalan with G-CSF-stimulated whole blood rescue followed by stem cell harvesting and busulphan/cyclophosphamide with autologous stem cell transplantation in multiple myeloma 2001 ·Bone Marrow Transplantation ·P.C. Huijgens, (unknown), (unknown), (unknown), Sonja Zweegman, GJ Schuurhuis, GJ Ossenkoppele	22
14	A randomized study of granulocyte colony-stimulating factor applied during and after chemotherapy in patients with poor risk myelodysplastic syndromes: a report from the HOVON Cooperative Group 1999 ·Leukemia ·GJ Ossenkoppele, Bronno van der Holt, (unknown), (unknown), LF Verdonck, Pieter Sonneveld, P. W. Wijermans, J. van der Lelie, WLJ van Putten, Bob Löwenberg, (unknown)	20
15	A randomized study of granulocyte-colony stimulating factor applied during and after chemotherapy in patients, with poor risk myelodysplastic syndromes: A final report from the Hovon Cooperative Group. 1998 ·Data Archiving and Networked Services (DANS) ·GJ Ossenkoppele, Bronno van der Holt, (unknown), (unknown), LF Verdonck, Pieter Sonneveld, P. W. Wijermans, J. van der Lelie, WLJ van Putten, Bob Löwenberg	1
16	Theoretical and practical considerations for the measurement of P-glycoprotein function in acute myeloid leukemia 1997 ·Leukemia ·(unknown), J. Lankelma, H. M. Pinedo, CA Eekman, (unknown), GJ Ossenkoppele, GJ Schuurhuis	34
17	A tetrazolium-based colorimetric MTT assay to quantitate human monocyte mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemia breakdown → 1994 ·Journal of Immunological Methods ·Arjan A. van de Loosdrecht, R.H.J. Beelen, GJ Ossenkoppele, Marjolein G. Broekhoven, M. M. A. C. Langenhuijsen	656
18	Effects of the ACTH(4-9) analogue, ORG 2766, on vincristine cytotoxicity in two human lymphoma cell lines, U937 and U715 1994 ·British Journal of Cancer ·(unknown), Arjan A. van de Loosdrecht, Karin Schweitzer, GJ Ossenkoppele, L Müller, J.J. Heimans, Peter C. Huijgens	7
19	Long term effects of vincristine on the peripheral nervous system 1993 ·Journal of Neuro-Oncology ·T.J. Postma, (unknown), Peter C. Huijgens, GJ Ossenkoppele, J.J. Heimans	115
20	A Pilot Study on the Influence of a Corticotropin (4-9) Analogue on Vinca Alkaloid--Induced Neuropathy 1992 ·Archives of Neurology ·(unknown), H.A.M. van Diemen, (unknown), Peter C. Huijgens, GJ Ossenkoppele, J. J. P. Nauta, J.J. Heimans	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact